课题基金 / 基金详情

MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS IN PRETERM PREMATURE

MATERNAL DDAVP FOR TREATMENT OF OLIGOHYDRAMNIOS IN PRETERM PREMATURE
母体 DDAVP 用于治疗早产儿睡眠不足
批准号：
6264912
负责人：
Michael Glenn Ross
金额：
$0.1万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6264912
关键词：
amniotic fluid clinical research female female reproductive system disorder human pregnant subject human subject human therapy evaluation premature labor

项目摘要

项目成果

Michael Glenn Ross的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Currently investigating the use of maternal dDAVP for patients with oligo-hydramnios and intact amniotic membranes at term. Potential beneficial use of dDAVP is for the treatment of those patients with spontaneous rupture of amniotic membranes. We propose to examine the potential therapeutic use of maternal dDAVP for patients with oligohydramnios and spontaneous rupture of membranes prior to term (less than 34 weeks).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Programmed Gestational Hyperphagia
Mechanisms of Programmed Gestational Hyperphagia
Mechanisms of Programmed Gestational Hyperphagia
Mechanisms of Programmed Gestational Hyperphagia
海外基金